Europe’s Leading Provider for human-based materials for the Diagnostics and Life Sciences Industry
What sets us apart?
Our consistent and dependable supply of both positive and negative plasma has established us as a valued partner in the diagnostic industry for many years. Our reputation for finding solutions to even the most challenging requests has been well-established.
Key to your success!
We offer the best of both worlds: the stability and expertise of a larger organization combined with the agility and adaptability of a smaller one. Our professional infrastructure and proven processes are matched by our willingness to take on new challenges.
BIMEX in Short
Since 2019, BIOMEX has had a special permit to export Disease State Plasma and patient samples to China.
„Every brilliant experiment, like every great work of art, starts with an act of imagination.“
We grow: Acquisition of Atreide Biosamples, a recognized specialist in the sourcing of tumorous tissue samples for the life science industry.
BIOMEX successfully completes the 155th SARSCov2 Corona rapid test validation, becoming the company with the highest number of Corona assay validations.
Opening of the Chinese subsidiary – Neckar Biotechnology – in Shanghai.
Launch of the new campaign “Join our Journey”, which communicates the progress of BIOMEX in the new segments.
Expansion of the product portfolio to include tissue, PBMC`s and cfDNA to serve the LifeScience industry.
Quality and Certification
Our focus is on providing high quality samples that are essential for research. This is why we are certified according to DIN EN ISO 9001: 2015. All of our services are oriented towards the requirements of GCP / GCLP, GDP and GLP.
Our motivation is to offer the best possible service when it comes to flexibly and reliably implementing customer specifications. We follow the principle of continuous improvement – all processes are permanently being monitored and optimized. Our quality management system is regularly checked and confirmed by internal and external audits.
Nevertheless, we can still look back on more than three decades of active business operations in the diagnostic and life science industry and incorporate this expertise and the know-how gained into all our projects.
All of our projects comply with the requirements of the ethics committee of the RP Bavaria, while all our actions are also subject to the following regulatory requirements:
Current milestones of our quality management
We have a strong presence in Europe, but we see the development of global markets as a key success factor – for ourselves and for progress in the service of health. Geographically, our focus is on Europe, Asia and North America. For customers based there, we source and supply human samples and conduct studies for the approval of products in Europe in accordance with the IVDR.
For our Chinese customers, we have opened a branch office in Shanghai to provide the best possible local support.
InVitro diagnostics has represented our largest customer segment to date. In 2021, we have expanded our business segment to serve the Life Sciences industry with high quality products and services.